Summary
The duration and extent of the reduction of exercise-induced tachycardia, as a measure of cardiac beta-adrenoceptor blockade were studied in 12 healthy volunteers after administration of single oral doses of pindolol 15 mg (Visken) or 160 mg slow release oxprenolol (Slow-Trasicor). The mean maximum effect was reached after 1.6±0.3 h with pindolol and after 2.5±0.2 h with slow release oxprenolol. The reduction in heart rate during exercise was virtually identical after both drugs, amounting to −36.1±1.7 beats/min after pindolol and −36.3±1.6 beats/min after slow release oxprenolol. The duration of action of pindolol, however, was clearly longer than that of slow release oxprenolol: after 24 h pindolol still exerted 39.6±5.6% of its maximum activity, as against 22.1±3.6% for slow release oxprenolol.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aellig, W. H.: Beta-adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers. Br. J. clin. Pharmacol.3, 251–257 (1976)
Frithz, G.: Initiation of once daily pindolol treatment. Br. med. J.1978/I, 302
General Practitioner Research Group, Rep. No.148: Dosage schedules in general practice. Practitioner204, Suppl. 10, 719–723 (1970)
Goldstraw, P. W., Taylor, S. H., Thadani, U., Watt, S. J.: Slow release oxprenolol in angina pectoris. Br. J. clin. Pharmacol.4, 387 (1977)
Gugler, R., Bodem, G., Dengler, H. J.: Plasmaspiegel von Pindolol (Visken®) unter Dauerbehandlung, berechnet aus der Pharmakokinetik nach Einzeldosis. Verh. Dtsch. Ges. Inn. Med.82, 1689–1692 (1976)
Meier, J.: Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents. Curr. Med. Res. Opin.4, Suppl. 5, 31–38 (1977)
Porter, A. M. W.: Drug defaulting in a general practice. Br. med. J.1969/I, 218–222
Robinson, B. F.: Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris. Circulation35, 1073–1083 (1967)
Rosenthal, J., Kaiser, H., Hammerschmidt, D., Welzel, D.: Praxis der Hochdrucktherapie mit einem Beta-Rezeptorenblocker — eine Multizenterstudie mit Visken 15 mg. Med. Welt28, 1969–1974 (1977)
Watt, M., Duncan, T. D.: Once daily administration of a betablocker in hypertension. N. Z. med. J.87, 126–128 (1978)
West, M. J., Kendall, M. J., Mitchard, M.: A comparison of slow-release with conventional oxprenolol: plasma concentrations and clinical effects. Br. J. clin. Pharmacol.3, 439–443 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aellig, W.H. Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers. Eur J Clin Pharmacol 14, 167–169 (1978). https://doi.org/10.1007/BF02089955
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02089955